Latest news
AUROPHARMA: Revenue up 16% YoY, EBITDA margin at 21%, guidance for double-digit growth reaffirmed - TradingViewTradingView · Thu, 06 Aug 2026 05:41:00 GMTAurobindo Pharma Q1FY27 net profit jumps 25% to record Rs1,032 crore, on broad-based growth - TradingViewTradingView · Wed, 05 Aug 2026 17:35:45 GMTAUROPHARMA: Q1 FY27 saw robust revenue and profit growth, boosted by the Lannett acquisition and share buyback - TradingViewTradingView · Wed, 05 Aug 2026 14:39:59 GMTAUROPHARMA: Revenue up 16.3% and net profit up 25.2% year-over-year, driven by broad-based growth - TradingViewTradingView · Wed, 05 Aug 2026 14:31:07 GMTAurobindo Pharma Q1 Consol Net PAT 10.33 Billion Rupees - TradingViewTradingView · Wed, 05 Aug 2026 14:28:02 GMT